Related Experiment Video
Updated: May 30, 2026
11:35
Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)
Published on: August 21, 2016
Emerging technologies from the Human Genome Project for understanding susceptibility and risk
1Human Genome Program, Lawrence Berkeley National Laboratory, 459 Donner Laboratory, Berkeley, CA 94720, USA.
Environmental Toxicology and Pharmacology
|July 26, 2011
Summary
New human genome technologies allow rapid genetic screening for disease risk. Ethical considerations arise with individual genetic information and potential group identifiers, posing challenges for risk assessment.
Area of Science:
- Genomics
- Environmental Health Science
- Bioethics
Background:
- The Human Genome Program has developed advanced technologies for assessing human exposure and individual susceptibility.
- These advancements enable the identification of specific genes linked to increased health risks, including oncogenes, tumor suppressor genes, and DNA repair enzymes.
Purpose of the Study:
- To explore the implications of new human genome technologies for population screening and risk assessment.
- To identify the ethical challenges associated with genetic screening and the use of individual genetic information.
Main Methods:
- Utilizing new technologies from the Human Genome Program for surveying human exposure.
- Implementing rapid genotyping technologies for screening populations for specific risk-associated genes.
Main Results:
- Technologies facilitate rapid screening of at-risk populations and the general public for various disease-associated genes.
- The use of rapid genotyping introduces specificity and potential group identifiers.
Conclusions:
- New genomic technologies offer powerful tools for personalized risk assessment and public health surveillance.
- Ethical considerations regarding genetic privacy, data use, and potential group discrimination must be addressed.
- These technologies present novel challenges for environmental risk determination within regulatory frameworks like the EPA mandate.
More Related Videos
Related Concept Videos
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
02:02Genomics
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:28Human Genetics
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
03:00Next-generation Sequencing
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
02:46Genetic Screens
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...